OPPM
GILD icon

Opus Point Partners Management’s Gilead Sciences GILD Stock Holding History

Opus Point Partners Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,000
Closed -$716K – 55
2017
Q4 		$716K Hold
10,000
– – 0.62% 38
2017
Q3 		$810K Hold
10,000
– – 0.73% 36
2017
Q2 		$706K Hold
10,000
– – 0.65% 40
2017
Q1 		$679K Buy
+10,000
New +$703K 0.5% 39

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Opus Point Partners Management's GILD Position: Q3 2019 in Review

Opus Point Partners Management held its Gilead Sciences (GILD) position steady in Q3 2019 at 4,082 shares worth $259K. The position accounts for 0.47% of the portfolio, ranked #48.

Opus Point Partners Management first reported a position in GILD in Q4 2014 and has held it in 18 quarters since. The position peaked at $3.41M in Q4 2015. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Opus Point Partners Management held 4,082 shares of Gilead Sciences worth $259K as of Q3 2019.
  • Opus Point Partners Management left its Gilead Sciences share count unchanged in Q3 2019.
  • Gilead Sciences made up 0.47% of Opus Point Partners Management's portfolio in Q3 2019, its #48 holding.
  • Opus Point Partners Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 18 quarters since.
  • Opus Point Partners Management's Gilead Sciences position peaked at $3.41M in Q4 2015.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.